NAYUKI (02150) repurchased 2.39 million shares on November 19 for approximately HK$1.5719 million.
NAYUKI (02150) announced that on November 19, 2026, it repurchased 2.39 million shares for approximately HK$1.5719 million.
NAYUKI (02150) announced that on November 19, 2026, it repurchased 2.39 million shares for approximately HK$1.5719 million.
Related Articles

Yinchuan Xinhua Commercial (600785.SH) has cumulatively repurchased 8.85% of its shares, spending approximately RMB300 million.

GRAND PHARMA (00512): Globally Innovative Nebulized Inhalant GPN01564 for the Treatment of Respiratory Syncytial Virus Approved to Initiate Phase I Clinical Study

Aotop Technology (688845.SH) IPO priced at RMB18.18 per share, subscription opens on November 23.
Yinchuan Xinhua Commercial (600785.SH) has cumulatively repurchased 8.85% of its shares, spending approximately RMB300 million.

GRAND PHARMA (00512): Globally Innovative Nebulized Inhalant GPN01564 for the Treatment of Respiratory Syncytial Virus Approved to Initiate Phase I Clinical Study

Aotop Technology (688845.SH) IPO priced at RMB18.18 per share, subscription opens on November 23.






